Drug class
Benzodiazepine hypnotic; positive allosteric modulator of GABAA receptors
Mechanism of action
Binds the benzodiazepine site on GABAA receptor complexes and enhances GABA-mediated chloride-channel opening, increasing neuronal inhibition and producing sedative, hypnotic, anxiolytic, muscle-relaxant and anticonvulsant effects.
General use cases
- Short-term treatment of severe insomnia in countries where flunitrazepam is authorised; it is controlled or not marketed in several jurisdictions because of abuse, dependence and diversion risks
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
